Status:
COMPLETED
Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Hematopoietic Neoplasms
Hematopoietic Malignancy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main purpose of this study is to determine if a novel peer support intervention (STEPP) is feasible among patients undergoing hematopoietic stem cell transplantation (HSCT). The name of the inter...
Detailed Description
The goal of this project is to refine a peer support intervention (STEPP) for patients undergoing hematopoietic stem cell transplantation (HSCT) and to conduct a randomized clinical trial to test its ...
Eligibility Criteria
Inclusion
- Adult patients (age \> 18 years) with a hematologic malignancy undergoing autologous or allogeneic HSCT.
- Ability to comprehend, read, and respond to questions in English as STEPP is only available in English.
Exclusion
- Patients undergoing HSCT for benign hematologic conditions.
- Patients undergoing outpatient HSCT.
- Patients with acute or unstable psychiatric or cognitive conditions which the treating clinicians believes prohibits informed consent or compliance with study procedures.
- Patients undergoing HSCT for the second time.
Key Trial Info
Start Date :
February 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 21 2025
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT06010017
Start Date
February 20 2024
End Date
March 21 2025
Last Update
August 5 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115
2
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02215